Managing lupus patients during pregnancy

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 4, 2009, Pages 575-582

  Ruiz Irastorza, Guillermo ^a   Khamashta, Munther A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

anti cardiolipin; foetal death; lupus anticoagulant; miscarriage; pre eclampsia; systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CALCIUM; CHLOROQUINE; CORTICOSTEROID; COUMARIN; CYCLOPHOSPHAMIDE; DALTEPARIN; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; LA ANTIBODY; LABETALOL; LEFLUNOMIDE; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METHYLDOPA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PREDNISONE; RITUXIMAB; RO ANTIBODY; STEROID; UNINDEXED DRUG; VITAMIN D; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGENITAL HEART BLOCK; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIABETES MELLITUS; DRUG MEGADOSE; DRUG SAFETY; EARLY DIAGNOSIS; EMBRYOPATHY; FETUS DISTRESS; FLUID RETENTION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; OBSTETRIC CARE; PATIENT COUNSELING; PLACENTA CIRCULATION; PLACENTAL TRANSFER; POSTNATAL CARE; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEINURIA; PULMONARY HYPERTENSION; REVIEW; SIDE EFFECT; SPINAL ANESTHESIA; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOSIS PREVENTION;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE;

EID: 67649784871     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.04.004     Document Type: Review

References (49)

1. Clowse M.E.B., Jamison M., Myesr E., and James A.H. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199 (2008) 127.e1-127.e6
2. Andrade R.M., McGwin Jr. G., Alarcon G.S., et al. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology 45 (2006) 1380-1384
3. Chakravarty E.F., Colón I., Langen E.S., et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192 (2005) 1897-1904
4. Andrade R., Sanchez M.L., Alarcon G.S., et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol 26 (2008) 268-274
5. Ruiz-Irastorza G., and Khamashta M.A. Lupus and pregnancy: ten questions and some answers. Lupus 17 (2008) 416-420
6. Moroni G., and Ponticelli C. Pregnancy after lupus nephritis. Lupus 14 (2005) 89-94
7. Lima F., Khamashta M.A., Buchanan N.M.M., et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14 (1996) 131-136
8. Ramsey-Goldman R., Kutzer J.E., Kuller L.H., et al. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 138 (1993) 1057-1069
9. Branch D.W., and Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101 (2003) 1333-1344
10. Mackillop L.H., Germain S.J., and Nelson-Piercy C. Systemic lupus erythematosus. Br Med J 335 (2007) 933-936
11. Opatrny L., David M., Kahn S.R., et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33 (2006) 2214-2221
12. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
13. Brucato A., Frassi M., Franceschini F., et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44 (2001) 1832-1835
14. Izmirly P.M., Rivera T.L., and Buyon J.P. Neonatal lupus syndromes. Rheum Dis Clin North Am 33 (2007) 267-285
15. Germain S., and Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 15 (2006) 148-155
16. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R.V. Heart disease, pregnancy and systemic autoimmune diseases. In: Oakley C., and Warnes C.A. (Eds). Heart disease in pregnancy. 2nd edn. (2007), Blackwell Publishing 136-150
17. Cuadrado M.J., Mendonça L.L.F., Khamashta M.A., et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 42 (1999) S265
18. Bonnin M., Mercier F.J., Sitbob, et al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102 (2005) 1133-1137
19. Papageorghiou A.T., and Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 17 (2005) 584-590
20. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45 (2006) 332-338
21. Ostensen M., Khamashta M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209-227
22. Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin North Am 33 (2007) 27-35
23. Ruiz-Irastorza G., Khamashta M.A., Nelson-Piercy C., and Hughes G.R.V. Lupus pregnancy: is heparin a risk factor for osteoporosis?. Lupus 10 (2001) 597-600
24. Horlocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient: defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and anticoagulation). Reg Anesth Pain Med 28 (2003) 172-197
25. Wetzl R.G. Anesthesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 13 (2004) 699-702
26. Nelson- Piercy C. Handbook of obstetric medicine. 3rd edn. (2006), Informa Healthcare
27. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulphate in systemic lupus erythematosus. N Engl J Med 324 (1991) 150-154
28. Ruiz-Irastorza G., Egurbide M., Pijoan J., et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15 (2006) 577-583
29. Fessler B., Alarcón G., McGwin G.J., et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52 (2005) 1473-1480
30. Alarcón G., McGwin G., Bertoli A., et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 66 (2007) 1168-1172
31. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta M. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2008 Dec 22. [Epub ahead of print].
32. Clowse M., Magder L., Witter F., and Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 (2006) 3640-3647
33. Levy R., Vilela V., Cataldo M., et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10 (2001) 401-404
34. Petri M., Howard D., and Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 34 (1991) 1538-1545
35. Ruiz-Irastorza G., Lima F., Alves J., et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35 (1996) 133-138
36. Urowitz M.B., Gladman D.D., Farewell V.T., et al. Lupus and pregnancy studies. Arthritis Rheum 36 (1993) 1392-1397
37. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 36 (1997) 772-777
38. Clowse M.E.B., Magder L.S., and Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52 (2005) 514-521
39. Buyon J.P., Kalunian K.C., Ramsey-Goldman R., et al. Assessing disease activity in SLE patients during pregnancy. Lupus 8 (1999) 677-684
40. Ruiz-Irastorza G., Khamashta M.A., Gordon C., et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum 51 (2004) 78-82
41. Clowse M. Lupus activity in pregnancy. Rheum Dis Clin North Am 33 (2007) 237-252
42. Milne F., Redman C., Walker J., et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J 330 (2005) 576-580
43. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A., and on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007) 1791-1798
44. Carmona F., Font J., Cervera R., et al. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 83 (1999) 137-142
45. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R.V. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1 (2002) 298-304
46. Ruiz-Irastorza G., and Khamashta M.A. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 1051 (2005) 606-612
47. Bates S.M., Greer I.A., Pabinger I., et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 844S-886S
48. Empson M., Lassere M., Craig J., et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2 (2005 18) CD002859
49. Khamashta M.A., Ruiz-Irastorza G., and Hughes G.R.V. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 23 (1997) 15-30